Skip to main content
All lobbying filings

MERCK & CO, INC.

MERCK & CO, INC. filed a Q1 report for MERCK & CO INC on April 21, 2025.

Lobbying for MERCK & CO INC

All filings by MERCK & CO, INC. · Everything MERCK & CO INC has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 21, 2025
Expenses
$2,600,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
New Jersey

Official filing document

 Lobbyists on this filing 1
  • STEPHANIE MCBATH New on this filing
    Previously held: Sr. Legis. Asst., Rep. Newhouse; Legis. Asst., Aug., Rep. Newhouse; Legis. Asst./Press Asst., Rep. Stefanik; Intern, Rep. Stefanik.

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 4
Health Issues

H.R. 1244, Reducing Drug Prices for Seniors Act H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. H.R. 1503/S. 2916, Prescription Information Modernization Act of 2023 H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 S. 1040, Drug Competition Enhancement Act S. 1339, Pharmacy Benefit Manager Reform Act S. 2076 Pioneering Antimicrobial Subscriptions To End Up surging Resistance (PASTEUR) Act of 2021 Issues relating to, 340B program integrity; 340B of the Public Health Services Act; 340B issues; 340B drug pricing program; Drug pricing; Drug pricing and reimbursement issues; Prescription drug cost-sharing; Anti-microbial Resistance; Cost and value of medicines; Respiratory Syncytial Virus (RSV) immunization; Vaccines issues; Vaccine misinformation; Measles, Mumps, and Rubella (MMR) immunizations; Package inserts, labeling issues, and E-Labeling authorization legislation; Pharmaceutical supply channel issues; Drug shortage issues; Inflation Reduction Act (P.L. 117-169), issues relating to drug pricing provisions; FY-2025 Budget and Appropriations Legislation; Intellectual property protection and trade issues; WTO IP Waiver for COVID therapeutics; Animal Health; Animal Health Technology Issues; Animal Health Policy Issues: Animal Drug User Fee Act (ADUFA) & Funding for Electronic Animal Traceability; One Health Issues; General pharmaceutical issues; Vaccine Injury Compensation Program (VICP); Diversity in clinical trials; Accelerated approval reform; Pharmacy Benefit Manager (PBM) policy issues; Pharmacy Benefit Manager reforms; Food and Drug Administration issues; Public Health Issues.

Medicare/Medicaid

H.R. 1244, Reducing Drug Prices for Seniors Act Issues relating to, Medicare; Medicare Part B and D drug pricing issues; 340B program integrity; 340B of the Public Health Services Act; 340B drug pricing program; Drug pricing; Drug pricing and reimbursement issues; FY-2025 Budget and Appropriations Legislation; Medicaid drug rebate program (MDRP);

Taxation/Internal Revenue Code

Issues relating to, Tax reform and tax policy, generally; Tax Cuts and Jobs Act of 2017 (P.L. 115-97); Inflation Reduction Act (P.L. 117-169), provisions relating to budget reconciliation and taxes.

Animals

H.R. 8467, Farm, Food, and National Security Act of 2024 Issues relating to, United Stated Department of Agriculture; Animal and Plant Health Inspection Service; Final Rule regarding use of electronic identification eartags as official identification in cattle and bison (89 Fed. Reg. 39,541-39,566, May 9, 2024)

 Bills named in this filing 9
  • H.R. 1244
    Reducing Drug Prices for Seniors Act
  • H.R. 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
  • H.R. 1503
    Prescription Information Modernization Act of 2023
  • S. 2916
    Prescription Information Modernization Act of 2023
  • H.R. 1968
    Full-Year Continuing Appropriations and Extensions Act, 2025
  • S. 1040
    Drug Competition Enhancement Act
  • S. 1339
    Pharmacy Benefit Manager Reform Act
  • S. 2076
    PASTEUR Act of 2021
  • H.R. 8467
    Farm, Food, and National Security Act of 2024

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem